Literature DB >> 12808385

Dopamine agonist therapy for hyperprolactinemia.

Brandon J Bankowski1, Howard A Zacur.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808385     DOI: 10.1097/00003081-200306000-00013

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


× No keyword cloud information.
  5 in total

1.  Dopamine blocks stress-mediated ovarian carcinoma growth.

Authors:  Myrthala Moreno-Smith; Chunhua Lu; Mian M K Shahzad; Guillermo N Armaiz Pena; Julie K Allen; Rebecca L Stone; Lingegowda S Mangala; Hee Dong Han; Hye Sun Kim; Donna Farley; Gabriel Lopez Berestein; Steve W Cole; Susan K Lutgendorf; Anil K Sood
Journal:  Clin Cancer Res       Date:  2011-04-29       Impact factor: 12.531

Review 2.  Treatment of pituitary tumors: dopamine agonists.

Authors:  Gabriella Iván; Nikoletta Szigeti-Csúcs; Márk Oláh; György M Nagy; Miklós I Góth
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

Review 3.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

Review 4.  Managing Prolactinomas during Pregnancy.

Authors:  Mussa Hussain Almalki; Saad Alzahrani; Fahad Alshahrani; Safia Alsherbeni; Ohoud Almoharib; Naji Aljohani; Abdurahman Almagamsi
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-26       Impact factor: 5.555

5.  An assessment of serum prolactin levels among infertile women with galactorrhea attending a gynecological clinic North-West Nigeria.

Authors:  Emmanuel Ajuluchukwu Ugwa; Adewale Olufemi Ashimi; Mohammed Yusuf Abubakar; Idris Usman Takai; Okunade Taiwo Lukman; Hamzah Abdurrahman Lawal; Muhammed Abubakar Also; Amadi Ngozi Gift; Halimat Muhammed Kiri
Journal:  Niger Med J       Date:  2016 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.